UPDATE 2-Ohr Pharma's eye drug fails mid-stage study, shares plunge

March 27 (Reuters) - Ohr Pharmaceutical Inc said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, wiping out nearly two-thirds of the company's market...

from Reuters: Hot Stocks http://ift.tt/1Mb2KoM